Breaking News, Collaborations & Alliances

Lambda to Acquire Novum

Novum will retain its identity and will operate as a division of global CRO leader Lambda Therapeutic Research giving Lambda entry into the U.S. market

Lambda Therapeutic Research has reached an agreement to acquire Novum Pharmaceutical Research Services, a leading CRO in the U.S., in a private transaction. Terms were not disclosed.   Novum has numerous global clients served throughout its U.S. operations in Pennsylvania, North Dakota, Nevada and Texas. It will be a wholly-owned subsidiary of Lambda.  Lambda, based in India, has operations in India, Canada, Poland and the United Kingdom.   Mrs. Bindi Chudgar, managing director of Lambda, sa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters